Aytu BioPharma Inc (AYTU)
1.54
-0.20
(-11.75%)
USD |
NASDAQ |
Nov 14, 16:00
1.54
0.00 (0.00%)
After-Hours: 20:00
Aytu BioPharma Total Liabilities (Quarterly): 90.38M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 90.38M |
| March 31, 2024 | 98.09M |
| December 31, 2023 | 98.40M |
| September 30, 2023 | 100.72M |
| June 30, 2023 | 97.11M |
| March 31, 2023 | 106.30M |
| December 31, 2022 | 95.62M |
| September 30, 2022 | 96.09M |
| June 30, 2022 | 93.32M |
| March 31, 2022 | 107.68M |
| December 31, 2021 | 118.29M |
| September 30, 2021 | 116.23M |
| June 30, 2021 | 128.10M |
| March 31, 2021 | 128.41M |
| December 31, 2020 | 54.05M |
| September 30, 2020 | 50.21M |
| June 30, 2020 | 58.28M |
| March 31, 2020 | 73.25M |
| December 31, 2019 | 57.39M |
| September 30, 2019 | 28.70M |
| June 30, 2019 | 27.63M |
| March 31, 2019 | 22.30M |
| December 31, 2018 | 22.50M |
| September 30, 2018 | 7.855M |
| June 30, 2018 | 7.636M |
| Date | Value |
|---|---|
| March 31, 2018 | 10.62M |
| December 31, 2017 | 15.83M |
| September 30, 2017 | 14.89M |
| June 30, 2017 | 11.00M |
| March 31, 2017 | 7.395M |
| December 31, 2016 | 11.06M |
| September 30, 2016 | 13.01M |
| June 30, 2016 | 14.26M |
| March 31, 2016 | 4.420M |
| December 31, 2015 | 9.151M |
| September 30, 2015 | 7.951M |
| June 30, 2015 | 2.569M |
| March 31, 2015 | 9.650M |
| February 28, 2015 | 0.0609M |
| November 30, 2014 | 0.0552M |
| August 31, 2014 | 0.0505M |
| May 31, 2014 | 0.0495M |
| February 28, 2014 | 0.1534M |
| November 30, 2013 | 0.1334M |
| August 31, 2013 | 0.1205M |
| May 31, 2013 | 0.1155M |
| February 28, 2013 | 0.1079M |
| November 30, 2012 | 0.0941M |
| August 31, 2012 | 0.0824M |
| May 31, 2012 | 0.069M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
50.21M
Minimum
Sep 2020
128.41M
Maximum
Mar 2021
93.05M
Average
97.11M
Median
Jun 2023
Total Liabilities (Quarterly) Benchmarks
| enVVeno Medical Corp | 3.02M |
| Bristol-Myers Squibb Co | 76.47B |
| Telesis Bio Inc | 42.78M |
| CEL-SCI Corp | 15.60M |
| AIM ImmunoTech Inc | 9.613M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 118.10M |
| Shareholders Equity (Quarterly) | 27.72M |
| Debt to Equity Ratio | 0.5459 |
| Current Ratio | 0.9946 |
| Net Debt Paydown Yield | 11.43% |